Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2011-11-08

Clinical Trial Update: Ablation as First Line Treatment in Paroxysmal Atrial Fibrillation [NA]

View source ↗

Summary

Clinical trial update on ablation as first-line treatment for paroxysmal atrial fibrillation; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Paroxysmal Atrial Fibrillation | NA | Status: UNKNOWN